Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

28 August 2018 (10:05 - 10:55)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Professor Borislava Mihaylova

Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail

Increased mortality despite successful multifactorial cardiovascular risk reduction in healthy men. 40-year follow-up of the Helsinki businessmen study intervention trial

Professor T. Strandberg (Helsinki, FI)

Abstract Slides

Presentation thumbnail

Added predictive value of follow-up blood-pressure measurements after alteration of therapy on cardiovascular risk in patients with hypertension

Ms N. Jaspers (Utrecht, NL)

Abstract Slides

Presentation thumbnail

Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden

Doctor B. Shahim (Stockholm, SE)

Abstract Slides

Presentation thumbnail

Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Professor M. Banach (Lodz, PL)

Abstract Slides

Presentation thumbnail

Sex hormone-binding globulin, aging, and cardiovascular risk

Ms E. Aribas (Rotterdam, NL)

Abstract Slides

Access the full session

Session thumbnail

Controversies in cardiovascular risk assessment and prevention

The Event

ESC Congress 2018

28 August 2018 10:05 CET

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC TV Today

Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources